Home » Stocks » LBPS

4D pharma PLC (LBPS)

Stock Price: $12.94 USD 0.94 (7.86%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
After-hours: $12.94 0.00 (-0.03%) Apr 16, 5:58 PM
Market Cap 287.31M
Revenue (ttm) 690,000
Net Income (ttm) n/a
Shares Out 22.37M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $12.94
Previous Close $12.00
Change ($) 0.94
Change (%) 7.86%
Day's Open 12.00
Day's Range 11.83 - 12.94
Day's Volume 16,686
52-Week Range 11.40 - 15.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Leeds, UK, April 01, 2021 (GLOBE NEWSWIRE) -- 4D pharma plc (AIM: DDDD, NASDAQ: LBPS) (“4D”, the “Company” or, together with its subsidiaries, the “Group”), a pharmaceutical company leading the developm...

2 weeks ago - GlobeNewsWire

4D pharma PLC (LON:DDD, NASDAQ:LBPS) hailed 2020 as a “transformational year” for the company. In its full-year results statement, the company listed the publication of the first proof-of-concept data f...

2 weeks ago - Proactive Investors

LEEDS, United Kingdom--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD) ("4D" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug ...

Other stocks mentioned: LOAC
3 weeks ago - Business Wire

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (Nasdaq: LBPS; AIM: DDDD) ("4D pharma" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel...

Other stocks mentioned: LOAC
3 weeks ago - Business Wire

NEW YORK, March 18, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today the results of its speci...

Other stocks mentioned: LOAC
4 weeks ago - PRNewsWire

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD) ("4D" or the "Company"), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived...

Other stocks mentioned: LOAC
1 month ago - Business Wire

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, t...

Other stocks mentioned: LOAC
1 month ago - Business Wire

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, t...

Other stocks mentioned: LOAC
1 month ago - Business Wire

NEW YORK, Feb. 26, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Act...

Other stocks mentioned: LOAC
1 month ago - PRNewsWire

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, t...

Other stocks mentioned: LOAC
1 month ago - Business Wire

NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that on December 18, 2020...

Other stocks mentioned: LOAC
3 months ago - PRNewsWire

NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that on December 10, 2020...

Other stocks mentioned: LOAC
4 months ago - PRNewsWire

WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Longevity Acquisition Corporation (“Longevity”) (NASDAQ GS: LOAC) regarding possible breache...

Other stocks mentioned: LOAC
4 months ago - GlobeNewsWire

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, t...

Other stocks mentioned: FRPRF, LOAC, LOACU
4 months ago - Business Wire

NEW YORK, Nov. 20, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that it has elected to ex...

Other stocks mentioned: LOAC
4 months ago - PRNewsWire

NEW YORK, Nov. 17, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company" or "LOAC"), a publicly-traded special purpose acquisition company (SPAC), announced that in light ...

Other stocks mentioned: LOAC
5 months ago - PRNewsWire

About LBPS

4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company develops therapeutic candidates, such as MRx0518; MRx-4DP000 for the treatment of asthma and COVID-19; MRx0029 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, including MRx1299 for solid tumors, MRx0005 for neurodegeneration, MRx0006 for rheumatoid arthritis, and MRx0002 for multip... [Read more...]

Industry
Biotechnology
Founded
2014
CEO
Duncan Peyton
Employees
92
Stock Exchange
NASDAQ
Ticker Symbol
LBPS
Full Company Profile